Literature DB >> 33168104

Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries.

Sultan Ayoub Meo1, Abdulelah Adnan Abukhalaf2, Ali Abdullah Alomar2, Faris Jamal AlMutairi2, Adnan Mahmood Usmani2, David C Klonoff3.   

Abstract

BACKGROUND: This study aimed to assess the impact of 15 days before, 15 days during, and 15 days after the lockdown on the trends in the prevalence and mortality in 27 countries during COVID-19 pandemic.
METHODS: Twenty-seven countries were randomly selected from the different continents. The information on the trends in the prevalence and mortality due to COVID-19 pandemic in 27 countries was obtained from World Health Organization and lockdown data were obtained from concerned countries and their ministries. The impact of lockdown for 15 days before, 15 days during, and 15 days after the lockdown on the prevalence and mortality due to the COVID-19 pandemic in 27 countries was analyzed.
RESULTS: The findings showed that 15 days after the lockdown there was a trend toward a decline, but no significant decline in the mean prevalence and mean mortality rate due to the COVID-19 pandemic compared to 15 days before, and 15 days during the lockdown in 27 countries. The mean growth factor for number of cases was 1.18 and for mortality rate was 1.16.
CONCLUSIONS: The findings indicate that 15 days after the lockdown, daily cases of COVID-19 and the growth factor of the disease showed a declined trend, but there was no significant decline in the prevalence and mortality.

Entities:  

Keywords:  COVID 19; Epidemiological trends; Lockdown; Mortality; Prevalence; Quarantine

Mesh:

Year:  2020        PMID: 33168104      PMCID: PMC7652585          DOI: 10.1186/s40001-020-00456-9

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


Background

The “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) also known as COVID-19 pandemic”, originated in Wuhan, China, spread globally and has caused destruction of human health, lives, and economies [1]. As of July 02, 2020, this disease has involved 216 countries and has infected 10,533,038 people with a mortality rate of 512,842 (4.86%) [3]. The median incubation period for COVID-19 is 5.1 days, and can be up to 14 days. The incubation period of COVID-19 is important to understand in establishing, monitoring, surveillance and control of the disease [4]. The severe contagious nature of COVID-19 has led to an unhealthy situation across the world. The worldwide population is 7.6 billion [5], and the major part of the population, approximately 3.9 billion people, has been under lockdown and quarantined in their homes at some point [6]. The lockdown and quarantine polices have been implemented by many nations to minimize the spread of this disease and bring it under control. The lockdown includes isolation at homes, travel restrictions, and termination of all public events. Modern lockdown strategies have been enforced all over the world in order to prevent the COVID-19 infection from spreading even further [7]. Currently, no established vaccines and pharmacological interventions are known to effectively cure or prevent a COVID-19 infection, and public health measures such as lockdown, quarantine, and social distancing appear to be the only ways to curb the outbreak. Lockdown and quarantine can either be implemented on a voluntary basis, or if deemed necessary, can be legally imposed by the authorities, and may be applied at individual or community levels [8, 9]. The home quarantine, when scientifically and adequately applied and exercised according to modern principles and practices, can be an effective method for preventing the spread of contagious diseases, such as COVID 19. Globally, many countries have extended a lockdown, quarantine period for over 2 months. There are great concerns about the effectiveness and risks of long-term implementation of a lockdown and or quarantine [10]. Keeping in view the rapid transmission of COVID-19 cases globally, the present study aimed to investigate the impact of lockdowns for 15 days before, 15 days during and 15 days afterward on international epidemiological trends in the prevalence and mortality of COVID-19 cases.

Materials and methods

The present observational study was conducted in the “Department of Physiology, College of Medicine, King Saud University” during the period of May–June 2020. The data on the trends in the prevalence and mortality due to COVID-19 outbreak were acquired from World Health Organization [3]. The daily reports on COVID-19 published by the World Health Organization were carefully reviewed and data were collected [3]. The lockdown data were obtained from concerned countries and their ministries however, populations of the countries were obtained from the world bank [5]. Twenty-seven countries were randomly selected from the different continents. The information on the trends in the prevalence and mortality due to COVID-19 outbreak in these 27 countries was obtained from the World Health Organization [3] and lockdown data were obtained from countries and their allied organizations. We defined the growth factor as a ratio by which a quantity multiplies itself over time; it equals daily cases divided by cases on the preceding day. A growth factor of more than 1.0, indicates an increasing pattern of prevalence, whereas values between below 1.0 show a declining pattern [11]. This number is equivalent to the velocity of a car: positive means the car is moving forward and negative means the car is moving backward. We defined the growth factor per day as the change in growth factor from one day to the next. A positive growth factor indicates exponential growth in the number of cases and a negative growth factor per day indicates exponential decay in the number of new cases. This number is equivalent to the acceleration of a car: positive means the car is accelerating (speeding up) and its velocity is increasing more and more per time period and negative means the car is decelerating (slowing down) and its velocity is decreasing more and more per time period. A negative growth rate per day means an epidemic is coming under control because in that case, the number of new cases each day will be decreasing and heading in a direction toward no new cases in a day. The data were carefully recorded and examined because the pandemic has been evolving, with the numbers changing daily. We analyzed the impact of lockdown on the “prevalence and mortality due to COVID-19” outbreak in 27 countries by establishing an association between the numbers, 15 days before, 15 days during and 15 days after the end of the lockdown period.

Statistical analysis

The data were recorded and analyzed, and the results were expressed in numbers and percentages. The mean and SEM of prevalence and mortality cases was calculated. The growth factor, by which quantity multiplies itself over time; daily cases divided by cases on the previous day was calculated. A p-value < 0.05 was considered significant.

Results

The worldwide number of cases and deaths due to COVID-19 are presented in Table 1. The impact of the lockdown on the epidemiological trends is presented in Tables 2 and 3. These tables contain the mean number of cases and mean number of deaths, respectively, at 15 days before, 15 days during, and 15 days after the lockdown in 27 countries and correlations were established. Worldwide, the COVID-19 infection has involved 216 countries and territories, and has infected 10,533,038 people with a mortality rate of 512,842 (4.86%) (Table 1) during the period December 29, 2019 to July 02, 2020 (Table I). The majority of these coronavirus cases, was reported from the American Region 5,317,792(50.48%), European Region 2,747,810 (26.08%), Eastern Mediterranean Region 1,096,565 (10.41%), South-East Asia Region 833,735 (7.91%), African Region 318,432 (3.02%) and Western Pacific Region 218,704 (2.07%) (Table 1).
Table 1

Worldwide number of laboratory-confirmed cases and deaths due to Covid-2019 pandemic

NumberTotal(%)Number of deaths(%)
Total number of cases10,533,038100512,8424.86
Western Pacific Region218,7042.0774710.07
European Region2,747,81026.08198,4891.88
South-East Asia Region833,7357.9122,8610.21
Easter Mediterranean Region1,096,56510.4125,2860.24
American Region5,317,79250.48252,3962.39
African Region318,4323.0210,2720.09

World Health Organization, data updated on July 02, 20203

Table 2

COVID-19 pandemic: mean number of cases 15 days before, 15 days during and 15 days after the lockdown in 27 countries

Date of lockdownCountryCases 15 days before the lockdown (mean ± SEM)Cases 15 days during the lockdown (mean ± SEM)Cases 15 days after the lockdown (mean ± SEM)p value
March 24, 2020Algeria1.60 ± 0.6122.80 ± 5.51100.33 ± 17.050.0001
March 20, 2020Argentina6.40 ± 2.2269.07 ± 14.26101.27 ± 15.320.0003
March 23, 2020Australia68.53 ± 18.32313.13 ± 41.6853.53 ± 10.850.0001
February 25, 2020Bahrain0.007.20 ± 2.0419.20 ± 3.460.0002
March 12, 2020Belgium17.73 ± 6.48311.33 ± 56.921362.13 ± 73.780.0001
March 18, 2020Chile10.40 ± 5.33172.13 ± 44.15385.07 ± 19.890.0001
January 23, 2020China36.92 ± 14.251841.13 ± 313012.07 ± 902.450..0001
March 24, 2020Colombia13.00 ± 4.5585.93 ± 13.23171.33 ± 15.300.0001
April 1, 2020Cuba11.07 ± 4.3039.73 ± 3.9445.80 ± 3.040.0001
March 15, 2020Djibouti0.002.00 ± 0.8222.47 ± 6.240.0002
March 25, 2020Egypt20.47 ± 3.9972.27 ± 10.15168.80 ± 20.100.0001
March 17, 2020France431.53 ± 113.512493.60 ± 346.683578.53 ± 312.890.0001
March 23, 2020Germany1377.87 ± 491.514928.53 ± 311.993097.93 ± 286.010.0001
March 30, 2020Ghana9.07 ± 5.2528.60 ± 11.0173.67 ± 23.930.0638
March 25, 2020India31.67 ± 8.61317.00 ± 65.471147.47 ± 78.560.0001
March 9, 2020Italy490.93 ± 110.733450.87 ± 479.024777.27 ± 229.390.0001
March 24, 2020Nepal0.000.53 ± 0.242.40 ± 1.060.0003
March 30, 2020Nigeria4.20 ± 1.7817.20 ± 3.4166.27 ± 30.060.0428
April 1, 2020Pakistan120.80 ± 14.67274.87 ± 41.01712.80 ± 110.830.0001
March 15, 2020Philippines4.36 ± 1.5667.40 ± 24.63245.13 ± 51.650.0001
March 24, 2020Republic of the Congo0.44 ± 0.242.73 ± 1.549.13 ± 3.280.0676
March 31, 2020Russian Federation100.00 ± 24.601304.53 ± 227.845467.20 ± 820.220.0001
March 25, 2020Saudi Arabia50.13 ± 15.41144.33 ± 12.05787.67 ± 90.400.0001
March 26, 2020South Africa36.47 ± 11.9286.07 ± 25.22144.21 ± 19.760.0001
March 14, 2020Spain280.40 ± 97.023988.53 ± 690.016251.40 ± 381.660.0001
March 23, 2020United Kingdom320.53 ± 80.202852.80 ± 377.515162.40 ± 299.560.0001
March 17, 2020United States of America117.86 ± 38.089261.73 ± 2208.3829,391.40 ± 880.140.0001
Table 3

COVID-19 pandemic: mean number of deaths 15 days before, 15 days during and 15 days after the lockdown in 27 countries

Date of lockdownCountryDeaths 15 days before lockdown (mean ± SEM)Deaths 15 days during lockdown (mean ± SEM)Deaths 15 days after lockdown (mean ± SEM)p value
March 24, 2020Algeria0.07 ± 0.071.60 ± 0.4317.80 ± 3.070.0002
March 20, 2020Argentina0.13 ± 0.091.93 ± 0.486.13 ± 0.900.0003
March 23, 2020Australia0.33 ± 0.162.13 ± 0.482.13 ± 0.420.0001
February 25, 2020Bahrain0.000.000.27 ± 0.12N/A
March 12, 2020Belgium0.0011.87 ± 4.34186.60 ± 31.890.0001
March 18, 2020Chile0.000.80 ± 0.305.93 ± 0.770.0001
January 23, 2020China0.75 ± 0.2837.00 ± 5.55114.07 ± 12.780.2228
March 24, 2020Colombia0.13 ± 0.132.20 ± 0.5710.00 ± 1.250.0001
April 1, 2020Cuba0.27 ± 0.121.13 ± 0.292.47 ± 0.350.0001
March 15, 2020Djibouti0.000.000.13 ± 0.09N/A
March 25, 2020Egypt1.20 ± 0.405.00 ± 0.6612.73 ± 1.070.0001
March 17, 2020France9.73 ± 2.99191.27 ± 33.04908.80 ± 118.090.0001
March 23, 2020Germany4.47 ± 2.0991.13 ± 13.48218.13 ± 17.410.0001
March 30, 2020Ghana0.27 ± 0.150.27 ± 0.150.53 ± 0.340.7231
March 25, 2020India0.60 ± 0.279.33 ± 2.6936.60 ± 1.860.0001
March 9, 2020Italy24.27 ± 8.74340.67 ± 57.47736.80 ± 29.160.0001
March 24, 2020Nepal0.000.000.00N/A
March 30, 2020Nigeria0.07 ± 0.070.60 ± 0.242.00 ± 0.940.027
April 1, 2020Pakistan1.67 ± 0.505.47 ± 0.93 ± 18.53 ± 2.790.0001
March 15, 2020Philippines0.07 ± 0.074.40 ± 1.5917.13 ± 3.840.0001
March 24, 2020Republic of Congo0.000.33 ± 0.190.07 ± 0.070.1885
March 31, 2020Russian Federation0.60 ± 0.2910.73 ± 1.9858.33 ± 9.000.0001
March 25, 2020Saudi Arabia0.07 ± 0.072.67 ± 0.535.53 ± 0.340.0001
March 26, 2020South Africa0.001.20 ± 0.354.07 ± 1.130.0013
March 14, 2020Spain8.00 ± 3.27315.87 ± 67.56752.13 ± 33.080.0001
March 23, 2020The United Kingdom15.40 ± 4.86313.40 ± 66.70797.60 ± 35.450.0001
March 17, 2020United States of America3.87 ± 1.18157.13 ± 42.251534.73 ± 113.210.0001
Worldwide number of laboratory-confirmed cases and deaths due to Covid-2019 pandemic World Health Organization, data updated on July 02, 20203 COVID-19 pandemic: mean number of cases 15 days before, 15 days during and 15 days after the lockdown in 27 countries COVID-19 pandemic: mean number of deaths 15 days before, 15 days during and 15 days after the lockdown in 27 countries Regarding the impact of lockdown on the prevalence and mortality of the COVID-19 outbreak in 27 countries, we found that 15 days after the lockdown there was no decline in the mean prevalence and the mean number of daily deaths due to COVID-19 compared to 15 days before and 15 days during the lockdown (Tables 2 and 3). However, the growth rate in the number of new daily cases of COVID-19 per day (Fig.1) and growth rate in the number of deaths per day (Fig. 2) attributed to COVID-19 each showed a positive but declining trend 15 days after the lockdown period in most of the sampled countries. This data indicated a negative growth factor per day during the 15 days following the lockdown for new daily cases and for deaths per day. The growth factor per day results for new cases and deaths for each country are presented in Figs. 1 and 2. The change in growth rates and growth rates per day are expressed first as the difference between two time periods: pre-lockdown vs. lockdown and second between two time periods: lockdown vs. post-lockdown. The tables and figures illustrate that post-lockdown time periods, there was a declining rate of change per day for most of the 27 individual countries and for the entire 27-country cohort (Figs. 1 and 2).
Fig. 1

Growth factor of number of cases 15 days before, 15 days during and 15 days after lockdown

Fig. 2

Growth factor of number of deaths 15 days before, 15 days during and 15 days after the lockdown

Growth factor of number of cases 15 days before, 15 days during and 15 days after lockdown Growth factor of number of deaths 15 days before, 15 days during and 15 days after the lockdown Regarding the mean prevalence of COVID-19 cases 15 days before, 15 days during and 15 days after lockdown, we found that the mean numbers of cases in all these 27 countries increased and there was no significant impact of lockdown on the prevalence of COVID-19 cases (Tables 2 and 3). We quantified growth rate for new cases of COVID-19. The mean growth rate for number of cases on a daily basis was 1.18 and for mortality rate was 1.16. It was identified that, 15 days after the lockdown, the growth factor of the number of new daily cases was and the growth factor of daily deaths in these selected countries worldwide was decreased after the lockdown period.

Discussion

The COVID-19 pandemic is an emerging worldwide health problem which has infected millions of people globally2. The notion of lockdown was linked with the incubation period of COVID-19, which is a median of 5.1 days and can be up to 14 days [4]. The lockdown policies have been enforced in many countries to reduce the spread of COVID-19 [6]. For a treatment to be successful at keeping an epidemic under control it must first cause the rate of growth per day to become negative and the growth rate to the growth rate per day to become negative fall to below 1.0, which would indicate an exponential decay in the number of cases. In this study, we investigated the impact of 15 days before, 15 days during and 15 days after lockdown on the epidemiological trends in the prevalence and mortality because of the outbreak of novel coronavirus SARS-COV-2. We found that 15 days after the international lockdown there was no significant decline in the mean prevalence and mean mortality rate due to COVID-19 compared to 15 days before and 15 days during the lockdown in 27 countries. However, daily cases of COVID-19 and growth rates showed declining trends by the end of the 15 days after the lockdown period, leading to a critically important negative growth rate per day by the end of the lockdown period for both new daily cases and deaths. This negative growth rate per day in these two categories (meaning the increase in cases was decelerating) indicated that from a public health perspective, the lockdown had a positive effect on the pandemic. However, the growth rate never fell to below 1.0 immediately following the lockdown, so the lockdown was not sufficient to stop the pandemic, which is borne out by obvious international persistence of this infection and a growing worldwide death rate.2 This has caused countries to impose new lockdowns and encourage residents to isolate themselves in their houses. Nussbaumer-Streit et al. 2020 [12] in a recent review on lockdown demonstrated that this type of measure has had an effective impact at reducing the incidence and mortality of COVID-19 during the current pandemic. This article recommended that along with other public health procedures, lockdown should be enforced at an early stage to prevent the COVID-19 infection from spreading further. The study has shown evidence that lockdown measures are consistently beneficial, with quarantining of people who were exposed to confirmed or suspected cases preventing 44% to 81% of new cases and 31% to 63% deaths, compared to a lack of any lockdown measure. The authors showed that a lockdown may prove helpful in controlling the COVID-19 outbreak. Our study showed that the lockdown was beneficial in decreasing the rate of growth per day of infection, but ultimately insufficient to bring the absolute growth rate down to 1.0 or less which is the point where an epidemic is clearly under control. The concept of a lockdown is theoretically attractive because it minimizes the number of people exposed to contagious patients and therefore fewer people will be susceptible to getting infected [13]. A lockdown may play an important role when vaccination or prophylactic treatment is not possible, as has been the case with COVID-19 pandemic. In this report, we analyzed the impact of 15 days before 15 days during and 15 days after a lockdown on the prevalence of COVID-19 cases in 27 countries. We found that daily cases of COVID-19 and growth factor results show a declined trends 15 days after the lockdown period. The present study findings did not support our hypothesis that lockdown will significantly decrease the number of cases. Manchein and colleagues 2020 [14] analyzed the growth of the cumulative number of COVID-19 cases from various countries until the last week of March 2020. Their study findings show that soft lockdown approaches are not suitable to flatten the growth curves. They also found that along with social distancing of individuals, the strategy of identifying and isolating infected individuals at daily basis and large levels can help to compress the curve. In addition, Bensimon and Upshur 2018 [15] and Greenberger 2018 [16] reported that the efficacy of a lockdown is uncertain. The present study findings are consistent with those of Manchein and colleagues 2020 [14], Bensimon and Upshur 2007 [15], and Greenberger, 2018 [16], that lockdowns or quarantines may also need additional supportive measures such as proper information, social distancing, and hygienic measures to eradicate an epidemic. In few countries there was a positive impact of lockdown to minimize the incidence of SARS-COV-2. But, this is also fact that, in many countries especially the developing countries long-term lockdown was not sustainable as it has various social, psychological and economic impact. Future lockdown policies should adhere to optimizing behavior such as social distancing and mask wearing associated with social and cultural factors that can affect in minimizing the COVID-19 pandemic, because lockdown alone will not be effective if people will not adhere to this policy.

Study strengths and limitations

This is the first article in the literature, to our knowledge, that has investigated the impact of a lockdown on epidemiological trends of prevalence and mortality of the COVID-19 pandemic, and our findings are based on the twenty seven countries worldwide. During the COVID-19 pandemic, to date, only mathematical modeling-based reviews have been published to hypothesize the impact of a lockdown on the prevalence of COVID-19 cases. This is the first study, which analyzed the impact of 15 days before, 15 days during and 15 days after lockdown on the prevalence trends of COVID-19. Another strength is that the study data were gathered using reliable sources including “World Health Organization, and concerned countries”. We also analyzed the growth factor and the growth rate per day, which are vital metrics to determine the epidemiological trends of a pandemic. A limitation is that we were unable to investigate confounding factors including how much people vary in: (1) adherence to lockdown, (2) adoption of protocols of social distancing, (3) practice of health hygienic conditions and (4) experience disease testing systems of their individual countries.

Conclusions

The present study findings show that 15 days after lockdown there was no significant decline in the mean prevalence and mean mortality rate due to novel coronavirus SARS-COV 2 compared to 15 days before and 15 days during the lockdown in 27 countries. Whereas daily cases of SARS-COV-2 patients, and the growth factor results declined and the growth rate per day both declined to an impressive negative level in the case of the growth rate per day by the time period of 15 days after the lockdown period, these two metrics of infection spreading did not fall sufficiently to control the pandemic. These findings may be useful for decision-makers who are contemplating further lockdowns to control the spread of the COVID-19 pandemic. Future lockdown policies should adhere to optimizing behavior such as social distancing and mask wearing associated with social and cultural factors that can affect spreading the COVID-19 pandemic, because lockdown alone will not be effective if people will not adhere to this policy.
  11 in total

1.  Evidence and effectiveness in decisionmaking for quarantine.

Authors:  Cécile M Bensimon; Ross E G Upshur
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

2.  Better Prepare Than React: Reordering Public Health Priorities 100 Years After the Spanish Flu Epidemic.

Authors:  Michael Greenberger
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

3.  Covid-19: Quarantine works when introduced early alongside other measures, finds review.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-04-09

4.  'Closing borders is ridiculous': the epidemiologist behind Sweden's controversial coronavirus strategy.

Authors:  Marta Paterlini
Journal:  Nature       Date:  2020-04       Impact factor: 49.962

5.  Life in the pandemic: Social isolation and mental health.

Authors:  Kim Usher; Navjot Bhullar; Debra Jackson
Journal:  J Clin Nurs       Date:  2020-05-06       Impact factor: 3.036

6.  Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.

Authors:  S A Meo; A M Alhowikan; T Al-Khlaiwi; I M Meo; D M Halepoto; M Iqbal; A M Usmani; W Hajjar; N Ahmed
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-02       Impact factor: 3.507

7.  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.

Authors:  Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-02-28       Impact factor: 17.586

8.  Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies.

Authors:  Cesar Manchein; Eduardo L Brugnago; Rafael M da Silva; Carlos F O Mendes; Marcus W Beims
Journal:  Chaos       Date:  2020-04       Impact factor: 3.642

9.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

10.  Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19.

Authors:  Sultan Ayoub Meo; Thamir Al-Khlaiwi; Adnan Mahmood Usmani; Anusha Sultan Meo; David C Klonoff; Thanh D Hoang
Journal:  J King Saud Univ Sci       Date:  2020-04-09
View more
  18 in total

Review 1.  Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection.

Authors:  Taif Shah; Zahir Shah; Nafeesa Yasmeen; Zulqarnain Baloch; Xueshan Xia
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

2.  Epidemiological trend and clinical profile of COVID-19 patients: Experience from a designated COVID-19 center in Delhi.

Authors:  Banke L Sherwal; Namrata Makkar; Ajeet Jain; Vikas Dogra; Shaleen Prasad; Ragi Jain; Aarti Gupta; Smita Gulati; Sonali Bhattar; Vikas Sharma; Shikhar Saxena; Payel Das; Mona Bargotya
Journal:  J Family Med Prim Care       Date:  2022-05-14

3.  Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies.

Authors:  Joe James; Shelley Rhodes; Craig S Ross; Paul Skinner; Samuel P Smith; Rebecca Shipley; Caroline J Warren; Hooman Goharriz; Lorraine M McElhinney; Nigel Temperton; Edward Wright; Anthony R Fooks; Tristan W Clark; Sharon M Brookes; Ian H Brown; Ashley C Banyard
Journal:  Viruses       Date:  2021-04-20       Impact factor: 5.048

Review 4.  Nonpharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic

Authors:  Mustafa Necmi Ilhan; Hakan Tüzün; Rahmi Kiliç; Nuran Yildirim
Journal:  Turk J Med Sci       Date:  2021-12-17       Impact factor: 0.973

5.  Impact of Workplace on the Risk of Severe COVID-19.

Authors:  Tsuyoshi Nakamura; Hiroyuki Mori; Todd Saunders; Hiroaki Chishaki; Yoshiaki Nose
Journal:  Front Public Health       Date:  2022-01-05

6.  Effectiveness of non-pharmaceutical public health interventions against COVID-19: A systematic review and meta-analysis.

Authors:  Shabnam Iezadi; Kamal Gholipour; Saber Azami-Aghdash; Akbar Ghiasi; Aziz Rezapour; Hamid Pourasghari; Fariba Pashazadeh
Journal:  PLoS One       Date:  2021-11-23       Impact factor: 3.240

7.  Sustained Effects of Government Response on the COVID-19 Infection Rate in China: A Multiple Mediation Analysis.

Authors:  Taixiang Duan; Zhonggen Sun; Guoqing Shi
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

Review 8.  The impact of COVID-19 on tuberculosis: challenges and opportunities.

Authors:  Surya Kant; Richa Tyagi
Journal:  Ther Adv Infect Dis       Date:  2021-06-09

9.  Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study.

Authors:  Ghodsiyeh Azarkar; Freshteh Osmani
Journal:  Eur J Med Res       Date:  2021-07-21       Impact factor: 2.175

10.  Forecasting daily new infections, deaths and recovery cases due to COVID-19 in Pakistan by using Bayesian Dynamic Linear Models.

Authors:  Firdos Khan; Shaukat Ali; Alia Saeed; Ramesh Kumar; Abdul Wali Khan
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.